Ascendis Pharma A/S (ASND): A Bull Case Theory

We came across a bullish thesis on Ascendis Pharma A/S on Tip Ranks’ YouTube Channel. In this article, we will summarize the bulls’ thesis on ASND. Ascendis Pharma A/S's share was trading at $215.05 as of January 13th. ASND’s forward P/E was 48.78, according to Yahoo Finance.

Ascendis Pharma (ASND) is a biopharma company specializing in innovative therapies for rare diseases, leveraging its proprietary Transcon technology platform to create long-acting prodrugs that improve dosing efficacy and patient compliance.

The company focuses primarily on endocrinology rare diseases,...